Dr. Steven M. Horwitz, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Lymphoma
Steven M. Horwitz, MD has run 9 trials for Lymphoma. Some of their research focus areas include:
T-Cell Lymphoma
Steven M. Horwitz, MD has run 6 trials for T-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Basking Ridge
Clinical Trials Steven M. Horwitz, MD is currently running
Mogamulizumab
for Preventing Adult T-Cell Leukemia/Lymphoma
The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for this type of cancer because they are infected with the HTLV-1 virus and because of changes seen in some of their immune system cells called T-cells.
Recruiting
1 award
Phase 2
5 criteria
Ruxolitinib + Duvelisib
for Lymphoma
This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts: dose escalation (Part 1), dose expansion (Part 2), and TFH/T-PLL cohort expansion (Part 3).
Recruiting
1 award
Phase 1
More about Steven M. Horwitz, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Steven M. Horwitz, MD has experience with
- Duvelisib
- Mogamulizumab
- Prednisone
- Lenalidomide
- Ruxolitinib
- Bortezomib
Breakdown of trials Steven M. Horwitz, MD has run
Lymphoma
T-Cell Lymphoma
Relapse
Peripheral T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven M. Horwitz, MD specialize in?
Steven M. Horwitz, MD focuses on Lymphoma and T-Cell Lymphoma. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage IV.
Is Steven M. Horwitz, MD currently recruiting for clinical trials?
Yes, Steven M. Horwitz, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Steven M. Horwitz, MD has studied deeply?
Yes, Steven M. Horwitz, MD has studied treatments such as Duvelisib, Mogamulizumab, Prednisone.
What is the best way to schedule an appointment with Steven M. Horwitz, MD?
Apply for one of the trials that Steven M. Horwitz, MD is conducting.
What is the office address of Steven M. Horwitz, MD?
The office of Steven M. Horwitz, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.